期刊文献+

Logistic回归和ROC曲线综合评价四种指标对原发性肝癌的诊断价值 被引量:7

Comprehensive Evaluation of the Diagnostic Value of Four Markers for Primary Hepatic Carcinoma by ROC Curve and Logistic Regression
下载PDF
导出
摘要 目的运用logistic回归与受试者工作特征曲线(ROC曲线)评价甲胎蛋白(AFP)、甲胎蛋白异质体(AFP-L3)、胸苷激酶(TK1)、分泌型蛋白Dickkopf-1(DKK1)对原发性肝癌(PHC)的诊断价值。方法选择76例原发性肝癌患者作为PHC组、42例良性肝脏疾病患者作为良性肝病组、32健康体检人员作为对照组,采用电化学发光法检测血清AFP水平;采用亲和吸附层析法检测AFP-L3水平,计算AFP-L3在AFP中比例;采用免疫印迹增强化学发光法检测血清TK1水平:采用ELISA试剂盒检测血清标本中DKKI水平。通过ROC曲线分析和Logistic回归结果的ROC曲线下面积(AUC),对4个指标单独及联合检测的临床性能行比较分析。结果 PHC组4个血清指标的含量明显高于良性肝病组及健康对照组,差异有统计学意义(P<0.05),AFP、AFP-L3、TK1和DKK1诊断PHC的敏感性分别为68.4%、76.3%、77.6%和80.3%,特异性分别为90.5%、91.9%、95.9%和94.6%。四项联合检测的敏感性和特异性为93.4%和89.2%;AFP、AFP-L3、TK1和DKK1的ROC曲线下面积(AUC)分别为0.755、0.808、0.913、0.814,联合检测的AUC为0.941,与AFP、AFP-L3、TK1和DKK1比较,差异均有统计学意义(P<0.05)。结论 AFP-L3、TK1和DKK1可以作为诊断PHC血清标志物,与AFP联合检测可提高诊断效能;Logistic回归结合ROC曲线可用于PHC多指标联合诊断的分析评价。 Objective By using logistic regression and ROC curve to analyze the diagnosis values of alpha- fetoprotein (AFP) 、 alpha- fetoprotein heterogeneity ( AFP- L3 ), serum thymidine kinase 1 ( TK1 ) 、 DKK1 in primary hepatic carcinoma (PHC). Methods There were 76 patients with primary hepatic carcinoma (PHC group), 42 patients with benign hepatic benign diseases (benign hepatic diseases group), and 32 healthy subjects (control group) enrolled in the study. AFP was detected by ECLIA; AFP-L3 was determined by adsorption centrifuging, and the ratio of AFP-L3 to AFP was calculated; and TK1 was determined by Western blot-enhanced chemiluminecence; DKK1 was detected byELISA method. The area under the ROC curve (AUC) of four factors and Logistic results were compared by clinic efficiency. Results All four factors in PHC group were significantly higher than that in benign hepatic diseases group and control group (P 〈 0.05). The sensibilities and specificities of AFP,AFP-L3~TK1 and DKK1 were 68.4% ,76.3% ~77.6% 80.3% and 90. 5% ,91. 9% ,95. 9% ,94. 6% respectively. The sensibility and specificity of combined examination was 93.4% and 89.2% ; the areas under the ROC curve(AUC) of four factors and the combined examination were 0. 755,0.808、0.913 、0. 814 and 0. 941 respectively ; allhad statistical difference with AFP, AFP-L3 TK1 and DKK1 (P 〈 0.05 ). Conclusion AFP-L3 、 TK1 and DKK1 can be used as serum markers for the diagnosis of PHC, and the combined examination of AFP 、 AFP-L3, TK1 and DKK1 could improve diagnostic performance of PHC. Logistic regression combined ROC curve is a simple and effective statistical method, and it can be used in the analysis and evaluation of multi-index combined diagnosis of PHC.
作者 冯茜
出处 《标记免疫分析与临床》 CAS 2016年第6期641-644,664,共5页 Labeled Immunoassays and Clinical Medicine
关键词 原发性肝癌 LOGISTIC回归 受试者工作特征曲线 联合检测 Primary hepatic carcinoma Logistic regression Roc curve Combined test
  • 相关文献

参考文献14

二级参考文献35

  • 1殷正丰,虞紫茜,崔贞福,胡韪,屠振兴,吴孟超.肝癌切除术后甲胎蛋白异质体含量变化及其临床意义[J].第二军医大学学报,1994,15(1):7-10. 被引量:5
  • 2刘扬,吴孟超,张柏和,钱光相,潘文舟,强美玉.抗人甲胎蛋白异质体单克隆抗体放射免疫检测原发性肝癌的临床研究[J].中华外科杂志,1996,34(9):530-532. 被引量:3
  • 3Ulmert D, Cronin AM, Bjork Th, et al. Prostatic-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case control study. BMC Med, 2008, 6, 1-22.
  • 4Li HX, Lei DS, Wang XQ, et al. Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer. Oncol Rep, 2005,13 : 145-149.
  • 5He Q, Zhzalg P, Zou L, et al. Concentration of thymidine kinase 1 in serum ( S-TK1 ) is a more sensitive proliferation marker in human solid tumors than its activity. Oncol Rep, 2005, 14: 1013- 1019.
  • 6Zhang J, Jia Q, Zou S, et al. Thymidine kinase 1 : a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients. Oncol Rep, 2006, 15 : 455-461.
  • 7He Q, Fomander T, Johansson H, et al. Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer. Anticancer Res, 2006, 26 : 4753-4759.
  • 8Wu C, Yang R, Zhou J, et al. Production and characterisation of a novel chicken IgY antibody raised against C-temainal peptide from human thymidine kinase 1. J Immunol Methods, 2003, 277: 157- 169.
  • 9Chen Z, Zhou H, Li S, et al. Serological thymidine kinase 1 ( STK1 ) indicates an elevated risk for the development of malignant tumours. Anticaner Res, 2008, 28: 3897-3907.
  • 10He Q, Wang N, Skog S, et al. Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation. Eur J Cell Biol, 1996, 70: 117-124.

共引文献14304

同被引文献82

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部